Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 30, 2011
Patent Application Number
10714195
Date Filed
November 14, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention concerns prognostic markers associated with EGFR positive cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed tissue samples of EGFR-expressing cancer, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.